Not provided
Not provided
Not provided
Not provided
Due to COVID-19, recruitment and enrollment was suspended and never resumed. COVID-related changes have been made to the clinical program which houses our intervention, and we could not compare new participants with our previous cohort.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| Sunnybrook Health Sciences Centre | OTHER |
| Toronto Rehabilitation Institute | OTHER |
| The Centre for Memory and Aging | UNKNOWN |
| University of Waterloo |
Not provided
Not provided
Not provided
Not provided
This study will explore the impact of an exercise and nutrition (EX+NUTR) , relative to exercise alone (EX) intervention, on brain structure and function as well as blood biomarkers in older adults with subjective cognitive decline (SCD) and vascular risk factors. The overall hypotheses are that a combined EX+NUTR, relative to EX, intervention will evoke more positive changes in brain structure (e.g. hippocampal volume), neural activity (e.g. task associated functional activations monitored through fMRI), and cognitive performance. These changes will be associated with an improved metabolic profile, reductions in inflammatory cytokines and oxidative burden, and greater intervention compliance.
All participants will engage in group supervised exercise sessions once per week as well as engage in additional exercise sessions at home 4 days/week. The exercise program will be run out of two sites (Toronto Rehabilitation Institute (TRI) - Rumsey Centre in Toronto, and the Centre for Community, Clinical Applied Research Excellence (CCCARE) at the University of Waterloo). The supervised exercise sessions modeled after the standard TRI Cardiovascular Prevention and Rehabilitation program, including aerobic training, resistance training and education/counseling. The active group will receive strategy training to simultaneously improve their diet in conjunction with our newly developed Brain Health Food Guide (EX+BHFG); the placebo control group (EX+BHEd) will receive brain health education to control for time and social participation. [NOTE All participants must also be enrolled in the SCD cohort of the CCNA and undergo the CCNA's COMPASS-ND assessment at the beginning of the trial.] The study is 6 months in duration and requires participants to attend 2.5 hr weekly sessions (1 hr supervised exercise, 0.5 hr exercise/stress education and 1 hr nutrition or brain health education) and to exercise on their own an additional 3-4 times per week. Participants are assessed on measures of cognition, brain health (MRI), functional status at baseline, post intervention and 6 month follow-up.
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Exercise plus Nutrition | Experimental | 6 months of supervised group exercise plus education and strategy training to alter diet to be consistent with recommendations outlined in our brain health food guide (BHFG). |
|
| Exercise | Active Comparator | Identical exercise to the experimental plus education and passive discussion about brain health and healthy lifestyle to control for experimental group nutrition sessions. |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Exercise plus nutrition | Behavioral | On the same day as the exercise class, participants will also receive nutrition support. Participants will alter their overall diet to be consistent with recommendations outlined in our brain health food guide (BHFG) and receive diet counseling and strategy training to promote retention and enable this dietary change. For the first two months, diet group sessions will be held on a weekly basis. For the remaining four months, sessions will be divided between group sessions and individual meetings with study dietitians, on a predefined schedule. Participants will submit weekly logs outlining diet goals, plans, successes and obstacles to help direct identification of sequential goals. |
| Measure | Description | Time Frame |
|---|---|---|
| Changes from baseline brain structure at 6 months and 12 months. | Cortical and subcortical grey matter density using MRI three-dimensional T1 weighted structural scan (MPRAGE) | 6 months plus 6 month follow-up |
| Measure | Description | Time Frame |
|---|---|---|
| Changes from baseline cerebral blood flow at 6 months and 12 months. | Pseudo-continuous arterial spin labeling MRI (pcASL) to quantify cerebral blood flow | 6 months plus 6 month follow-up |
| Changes from baseline cognition at 6 months and 12 months |
Not provided
Inclusion Criteria:
meeting criteria for subjective cognitive impairment (1 through 5 below)
Answer Yes to both following questions:
Have a delayed recall score on 1 paragraph of the Logical Memory test (Wechsler Memory Scale, maximum score 25) above the education-adjusted cut-offs:
Have a Montreal Cognitive Assessment (MoCA) total score of 20 and over (≥20/30).
Have a delayed recall score on the CERAD word list of 5 and over (≥5).
Have a global Clinical Dementia Rating score (CDR) equal to 0.5 or less (≤0.5).
≥2 vascular risk factors (overweight (BMI>25), T2DM, hypercholesterolemia or hypertension),
Consuming a poor quality diet (at least median or below on number of servings of vegetable, fruit, fish and nuts based on Canadian consumption patterns in older adults)
Reasonably sedentary (less than 75min per week of moderate - vigorous intensity physical activity)
Be available for the whole intervention (6 months) and a 12- month follow-up visit
English speaking
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Carol E Greenwood, PhD | Rotman Research Institute Baycrest Health Sciences | Principal Investigator |
| Nicole D Anderson, PhD | Rotman Research Institute Baycrest Health Sciences | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Toronto Rehabilitation Institute Rumsey Centre | Toronto | Ontario | M4G 2V6 | Canada | ||
| Sunnybrook Health Sciences Centre |
| PubMed Identifier | Type | Citation | Retractions |
|---|---|---|---|
| 35139918 | Derived | Koblinsky ND, Anderson ND, Ajwani F, Parrott MD, Dawson D, Marzolini S, Oh P, MacIntosh B, Middleton L, Ferland G, Greenwood CE. Feasibility and preliminary efficacy of the LEAD trial: a cluster randomized controlled lifestyle intervention to improve hippocampal volume in older adults at-risk for dementia. Pilot Feasibility Stud. 2022 Feb 9;8(1):37. doi: 10.1186/s40814-022-00977-6. |
Not provided
Not provided
data will be uploaded to shared CCNA database - LORIS
Not provided
Not provided
Not provided
Not provided
| Type | Date | Date Unknown |
|---|---|---|
| Release | Sep 30, 2022 | |
| Reset | Aug 21, 2023 | |
| Release | Apr 9, 2024 | |
| Reset | Apr 19, 2024 |
Not provided
Not provided
| Release Date | Unrelease Date | Unrelease Date Unknown | Reset Date | MCP Release Number |
|---|---|---|---|---|
| Sep 30, 2022 | Aug 21, 2023 | |||
| Apr 9, 2024 |
| ID | Term |
|---|---|
| D015444 | Exercise |
| D009752 | Nutritional Status |
| ID | Term |
|---|---|
| D009043 | Motor Activity |
| D009068 | Movement |
| D009142 | Musculoskeletal Physiological Phenomena |
| D055687 | Musculoskeletal and Neural Physiological Phenomena |
Not provided
Not provided
| OTHER |
Not provided
Not provided
Not provided
Not provided
|
| Exercise | Behavioral | Supervised group exercise will be performed once per week (60 minutes) and self-directed exercise (4 additional aerobic and 2-3 resistance training sessions per week) will be monitored by an exercise diary. The initial walking prescription will be set at ~1.6 km and an intensity equivalent to the anaerobic threshold and/or 60% VO2-peak. Progressions will be made every 2 weeks, increasing distance to a maximum of 6.4 km and then increasing to a max intensity of 80% of VO2-peak and/or max duration of 60 minutes. Heart rate and perceived exertion will be monitored. The program will last 6 months. |
|
pen and paper and computerized tasks, monitoring memory, executive function, and speed of processing. The results will be presented as a composite score of total neuro-psychological performance aggregating scores from the above cognitive domains.
| 6 months plus 6 month follow-up |
| Changes from baseline brain activity related to attention at 6 months and 12 months | BOLD functional MRI while participants performing an attention task | 6 months plus 6 month follow-up |
| Changes from baseline resting state connectivity at 6 months and 12 months | BOLD functional MRI while participants at rest | 6 months plus 6 month follow-up |
| Changes from baseline diet quality at 6 months and 12 months | Principle component analyses based on Canadian Diet History Questionnaire II (C-DHQII) | 6 months plus 6 month follow-up |
| Changes from baseline adherence to diet recommendations at 6 months and 12 months | Principle component analyses based on the Eating Pattern Self-Assessment | 6 months plus 6 month follow-up |
| Changes from baseline grip strength at 6 months and 12 months | Grip strength using a hand held dynamometer | 6 months plus 6 month follow-up |
| Changes from baseline gait performance at 6 months and 12 months | Gait velocity, stride length/width, and associated variability assessed using a GAITRite pressure sensor mat. | 6 months plus 6 month follow-up |
| Changes from baseline balance performance at 6 months and 12 months | Posturography assessment on balance platform | 6 months plus 6 month follow-up |
| Changes from baseline maximal oxygen uptake at 6 months and 12 months | VO2max determined during cardiopulmonary assessment | 6 months plus 6 month follow-up |
| Changes from baseline blood moderators at 6 months and 12 months | e.g. BDNF, pro-BDNF, ApoE, | 6 months plus 6 month follow-up |
| Changes from baseline HbA1C at 6 months and 12 months | HbA1C | 6 months plus 6 month follow-up |
| Changes from baseline fasting glucose at 6 months and 12 months | fasting glucose | 6 months plus 6 month follow-up |
| Changes from baseline insulin levels at 6 months and 12 months | insulin | 6 months plus 6 month follow-up |
| Changes from baseline lipid levels at 6 months and 12 months | lipid profile | 6 months plus 6 month follow-up |
| Changes from baseline homocysteine levels at 6 months and 12 months | homocysteine | 6 months plus 6 month follow-up |
| Changes from baseline C reactive protein levels at 6 months and 12 months | CRP | 6 months plus 6 month follow-up |
| Changes from baseline TNF-alpha levels at 6 months and 12 months | TNF-alpha | 6 months plus 6 month follow-up |
| Changes from baseline IL6 levels at 6 months and 12 months | IL6 | 6 months plus 6 month follow-up |
| Changes from baseline vitamin K levels at 6 months and 12 months | Vitamin K | 6 months plus 6 month follow-up |
| Toronto |
| Ontario |
| M4N 3M5 |
| Canada |
| Rotman Research Institute | Toronto | Ontario | M6A 2E1 | Canada |
| Centre for Community, Clinical Applied Research Excellence (CCCARE) at the University of Waterloo | Waterloo | Ontario | Canada |
| Apr 19, 2024 |
| D009747 | Nutritional Physiological Phenomena |
| D000066888 | Diet, Food, and Nutrition |
| D010829 | Physiological Phenomena |
| D006304 | Health Status |
| D003710 | Demography |
| D011154 | Population Characteristics |